Refine
Document Type
- Article (2)
Language
- English (2) (remove)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- regulatory networks (2) (remove)
Institute
Abstract
Pikeperch (Sander lucioperca) has become a species of interest in aquaculture. It is a popular and economically valuable food fish and can produce high numbers of offspring. However, during early development, there are transition phases when high mortality rates concur with growth changes, vital organ transformations and a limited energy budget. Up to now, no study focused on the developmental adaption of muscle tissue in pikeperch, regardless of muscle tissue influencing essential traits such as locomotion and thus the competence to hunt prey and avoid predators. In the present study, therefore, the developmental myogenesis of pikeperch was analysed using specimens from early embryonic to larval development. Myogenic and developmental genes were utilized to gain insights into transcriptomic regulation during these stages by applying a nanofluidic qPCR approach. Result, three phases of myogenic gene expression, during somitogenesis, during the late embryonic development and during the larval development were detected. Increased myostatin expression showed an interim arrest of muscle formation between embryonic and larval myogenesis. Expression patterns of satellite cell gene markers indicated an accumulation of stem cells before myogenesis interruption. The here gained data will help to broaden the knowledge on percid myogenesis and can support pikeperch rearing in aquaculture.
Liver diseases are important causes of morbidity and mortality worldwide. The aim of
this study was to identify differentially expressed microRNAs (miRNAs), target genes, and key
pathways as innovative diagnostic biomarkers in liver patients with different pathology and functional
state. We determined, using RT-qPCR, the expression of 472 miRNAs in 125 explanted livers from
subjects with six different liver pathologies and from control livers. ANOVA was employed to
obtain differentially expressed miRNAs (DEMs), and miRDB (MicroRNA target prediction database)
was used to predict target genes. A miRNA–gene differential regulatory (MGDR) network was
constructed for each condition. Key miRNAs were detected using topological analysis. Enrichment
analysis for DEMs was performed using the Database for Annotation, Visualization, and Integrated
Discovery (DAVID). We identified important DEMs common and specific to the different patient
groups and disease progression stages. hsa-miR-1275 was universally downregulated regardless
the disease etiology and stage, while hsa-let-7a*, hsa-miR-195, hsa-miR-374, and hsa-miR-378 were
deregulated. The most significantly enriched pathways of target genes controlled by these miRNAs
comprise p53 tumor suppressor protein (TP53)-regulated metabolic genes, and those involved in
regulation of methyl-CpG-binding protein 2 (MECP2) expression, phosphatase and tensin homolog
(PTEN) messenger RNA (mRNA) translation and copper homeostasis. Our findings show a novel
panel of deregulated miRNAs in the liver tissue from patients with different liver pathologies. These
miRNAs hold potential as biomarkers for diagnosis and staging of liver diseases.